Description

Listing and trading of 41,06,181 equity shares of Camlin Fine Sciences Limited issued on preferential basis pursuant to share swap, effective January 5, 2026.

Summary

BSE has announced the listing and trading of 41,06,181 new equity shares of Camlin Fine Sciences Limited (Scrip Code: 532834) effective from Monday, January 5, 2026. These shares were issued to non-promoters on a preferential basis pursuant to a share swap arrangement at a price of Rs. 247.69 per share and are subject to lock-in until July 4, 2026.

Key Points

  • 41,06,181 equity shares of Re. 1/- each issued at a premium of Rs. 246.69
  • Shares issued to Non-Promoters on preferential basis pursuant to share swap
  • Issue price: Rs. 247.69 per share
  • Distinctive Numbers: 187980433 to 192086613
  • New shares rank pari-passu with existing equity shares
  • Scrip Code: 532834
  • ISIN: INE052I01032
  • Date of Allotment: November 30, 2025

Regulatory Changes

No regulatory changes announced in this circular.

Compliance Requirements

Trading members are informed of the new securities listing. The allotted shares are subject to lock-in restrictions and cannot be transferred until the lock-in period expires.

Important Dates

  • Date of Allotment: November 30, 2025
  • Trading Commencement Date: January 5, 2026 (Monday)
  • Lock-in Period Expiry: July 4, 2026
  • Circular Date: January 2, 2026

Impact Assessment

This is a routine listing announcement with minimal market impact. The preferential allotment increases the total equity base of Camlin Fine Sciences Limited by 41.06 lakh shares. The lock-in period until July 4, 2026 ensures that these shares cannot be traded freely for approximately 7 months from the trading commencement date, preventing immediate dilution impact. The share swap mechanism suggests a potential acquisition or restructuring activity by the company. Investors should note the ranking pari-passu status, meaning new shares have equal rights with existing shares.

Impact Justification

Routine listing of preferential allotment shares with lock-in period; limited market impact for company-specific securities issuance.